This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Entain PLC | 774.8 | 8.6% |
| Standard Chartered PLC | 912.6 | 4.1% |
| Croda International PLC | 3,734.0 | 3.1% |
| Imperial Brands PLC | 2,304.0 | 2.7% |
| Smith (Ds) PLC | 477.4 | 2.2% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Anglo American PLC | 2385.5 | -3.9% |
| GSK PLC | 1407.0 | -3.1% |
| Astrazeneca PLC | 11206.0 | -2.8% |
| Diageo PLC | 2450.0 | -2.6% |
| Spirax Group PLC | 6535.0 | -2.5% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 8,160 | -0.7% | 11.4% |
| DOW JONES INDUS. AVG | 42,142 | -0.2% | 27.5% |
| DAX INDEX | 19,257 | -1.1% | 30.0% |
| NIKKEI 225 | 39,081 | -0.5% | 26.7% |
| S&P/ASX 200 INDEX | 8,160 | -0.3% | 20.3% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 68.89 | 0.41% |
| Brent Crude (ICE) | USD/bbl. | 72.85 | 0.41% |
| Gold Spot | USD/t oz. | 2,779 | -0.3% |
| Copper (Comex) | USd/lb. | 435 | -0.1% |
Click graph to enlarge
The UK 100 called to open -23 points at 8,136. The UK 100 looks set to start today on the back foot as investors continue to digest the details of yesterday’s budget.
Stateside on Wednesday saw the S&P slide 0.33% to 5,813.67. The Dow Jones lost 91.51 points, or 0.22%, to close at 42,141.54. The tech-heavy Nasdaq declined 0.56% after earlier rising to a fresh record high. It closed at 18,607.93.
In focus today will be the Personal Consumption expenditure index for September. This tends to be the Federal Reserve’s preferred inflation indicator. Economists polled by Dow Jones expect that the PCE grew by 0.2% on a monthly basis and 2.1% from a year earlier.
Coca-Cola HBC raised its annual forecast and exceeded market estimates for third-quarter organic revenue growth on Thursday, supported by strong demand for energy, coffee and sparkling drinks. The quarterly revenue jump was fuelled by growth across all segments in volume, pricing, and mix, the company said.
Shell reported on Thursday third quarter profits of $6 billion that exceeded forecast by 12% as weaker refining and oil trading results were offset by higher gas sales. Shell’s adjust earnings, its definition of net profit, fell 4% from the previous three months and compared with analysts’ expectations of a $5.36 billion profit. The company said it will buy back a further $3.5 billion of its shares over the next three months, at a similar rate to the previous quarter. Its dividend remained unchanged at 34 cents per share.
Smith & Nephew this morning cut its annual underlying revenue growth forecast on Thursday to 4.5% from the previous outlook range of 5% to 6%, primarily hurt by challenges in its surgical businesses in China.
No New Broker Comments
UK
Coca-Cola HBC
Haleon
PPHE Hotel Group
Safestore Holdings
Shell
Smith & Nephew
Spectris
US
Ball Corp
Bristol-Myers Squibb
The Estee Lauder Companies
Mastercard
Merck & Co
Takeda Pharmaceutical
Uber Technologies
Willis Towers Watson
Amazon.com
Apple Inc
Intel Corp
UK
None
US
Chevron
Exxon Mobil
Chinese NBS Manufacturing PMI
Chinese NBS Non-Manufacturing PMI
BoJ Interest Rate Decision
BoJ Monetary Policy Statement
German Retail Sales
EU Economic Bulletin
EU Core Harmonized Index of Consumer Prices
EU Unemployment Rate
US Core Personal Consumption Expenditures
US Initial Jobless Claims
US Personal Income
US Personal Spending
Chicago Purchasing Managers’ Index
UK 100 companies going ex-dividend on 31st October 2024:
Whitbread
UK 250 companies going ex-dividend on 31st October 2024:
Balfour Beatty
Hilton Food Group
Dunelm Group
Renishaw
PZ Cussons
European Smaller Companies Trust
Tritax Big Box REIT
Edinburgh Investment Trust
VinaCapital Vietnam Opportunity Fund
Bloomsbury Publishing
GCP Infrastructure Investments
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.